Loading…
Zimmer Biomet Holdings, Inc. is projected to rise to $104.67 by 2027, a +27% move from its current price of $82.56. ZBH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $81.36 | $82.59 | $83.84 | +0.04% |
| May 30 | $80.89 | $82.63 | $84.40 | +0.08% |
| May 31 | $80.54 | $82.66 | $84.84 | +0.12% |
| Jun 1 | $80.25 | $82.69 | $85.22 | +0.16% |
| Jun 2 | $79.99 | $82.73 | $85.55 | +0.20% |
| Jun 3 | $79.77 | $82.76 | $85.86 | +0.24% |
| Jun 4 | $79.57 | $82.79 | $86.15 | +0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $79.57 | $82.79 | $86.15 | +0.28% |
| Week 2 | $78.49 | $83.03 | $87.83 | +0.56% |
| Week 3 | $77.72 | $83.26 | $89.19 | +0.85% |
| Week 4 | $77.12 | $83.50 | $90.40 | +1.13% |
| Week 5 | $76.61 | $83.73 | $91.51 | +1.42% |
| Week 6 | $76.18 | $83.97 | $92.55 | +1.70% |
| Week 7 | $75.80 | $84.20 | $93.54 | +1.99% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest.
It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups.
The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Zimmer Biomet Holdings, Inc. (ZBH) is currently priced at $85.50 per share with a market cap of $16.54B, ranking 653. The stock has a defined market position and is subject to a forecast that projects earnings and price movement over the coming years.
The 30-day price action and key technical levels provide context for near-term dynamics. The stock’s near-term technicals include a 30-day range and defined support and resistance levels.
A major floor 15.2% below — a decisive break under it would weaken the trend.
The nearest floor, 3.6% below — buyers have tended to step in here.
The nearest ceiling, 15.6% above — a clean break opens room to run.
A major ceiling 23.3% above — clearing it would confirm fresh momentum.
Key ZBH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ZBH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $84.63 | Sell | $84.12 | Sell |
| MA 10 | $84.34 | Sell | $84.25 | Sell |
| MA 20 | $83.30 | Sell | $84.92 | Sell |
| MA 50 | $88.06 | Sell | $87.43 | Sell |
| MA 100 | $90.23 | Sell | $89.71 | Sell |
| MA 200 | $93.95 | Sell | $92.70 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.25 | Neutral |
| Stoch RSI (14) | 52.68 | Neutral |
| CCI (20) | -39.32 | Neutral |
| Williams %R (14) | -54.15 | Info |
| MACD (12,26,9) | 0.37 | Buy |
| ROC (12) | 0.28 | Buy |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 45.85 | Neutral |
| TRIX (15) | -0.28 | Sell |
| Awesome (5,34) | -2.66 | Sell |
| Ultimate (7,14,28) | 42.35 | Neutral |
| Momentum (10) | -0.81 | Sell |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 84.38 | Sell |
| ADX (14) | 16.47 | Neutral |
| ATR (14) | 1.20 | Info |
Sentiment is BULLISH. The RSI14 is 50, with the SMA50 at $88.46 and the SMA200 at $94.11. Near-term support is at $79.58 and resistance is at $96.52. The 30-day price range is $77.44 to $94.40, outlining a constructive near-term band with upside potential within the current range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $79.58 | $82.56 | $111.10 | 0% | Neutral | |
| $85.50 | $104.67 | $134.11 | +27% | Bullish | |
| $88.30 | $110.07 | $144.71 | +33% | Bullish | |
| $91.62 | $115.93 | $155.59 | +40% | Bullish | |
| $102.30 | $131.16 | $179.15 | +59% | Bullish | |
| $103.68 | $134.54 | $186.63 | +63% | Bullish | |
| $117.51 | $154.20 | $216.90 | +87% | Bullish | |
| $141.58 | $187.73 | $267.45 | +127% | Bullish | |
| $147.76 | $197.86 | $285.22 | +140% | Bullish | |
| $153.86 | $207.95 | $303.09 | +152% | Bullish | |
| $219.98 | $310.06 | $473.44 | +276% | Bullish | |
| $360.54 | $544.93 | $891.65 | +560% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $79.58 | $82.56 | $96.73 | +0.00% |
| June 2026 | $72.70 | $84.81 | $100.85 | +2.72% |
| July 2026 | $73.00 | $85.65 | $102.81 | +0.99% |
| August 2026 | $72.16 | $85.05 | $102.84 | -0.69% |
| September 2026 | $73.55 | $87.00 | $105.83 | +2.29% |
| October 2026 | $75.85 | $90.03 | $110.10 | +3.48% |
| November 2026 | $75.74 | $90.17 | $110.79 | +0.15% |
| December 2026 | $75.40 | $90.02 | $111.10 | -0.17% |
Click any year to see its month-by-month ZBH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Zimmer Biomet Holdings, Inc.'s 2026 outlook centres on $82.56, within a $79.58 to $111.10 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, ZBH could reach as high as $134.11, with a base case around $104.67 and support toward $85.50 — roughly +27% from $82.56. Momentum favours further upside here.
Expect ZBH to range from $88.30 to $144.71 through 2028. The $110.07 average target implies a +33% move from current prices. That is up +5% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The ZBH price prediction for 2029 points to an average of $115.93 (low $91.62, high $155.59) — a potential gain of +40% on today's $82.56. Momentum favours further upside here.
In 2030, ZBH is projected to trade between $102.30 and $179.15, averaging $131.16 — a potential gain of +59% from today's $82.56. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Zimmer Biomet Holdings, Inc.'s 2031 outlook centres on $134.54, within a $103.68 to $186.63 range. That is up +3% on the projected 2030 average. That marks a +63% change versus current levels. Momentum favours further upside here.
By 2032, ZBH could reach as high as $216.90, with a base case around $154.20 and support toward $117.51 — roughly +87% from $82.56. Buyers look set to stay in control over this stretch.
Expect ZBH to range from $141.58 to $267.45 through 2033. The $187.73 average target implies a +127% move from current prices. That is up +22% on the projected 2032 average. Momentum favours further upside here.
The ZBH price prediction for 2034 points to an average of $197.86 (low $147.76, high $285.22) — a potential gain of +140% on today's $82.56. Buyers look set to stay in control over this stretch.
In 2035, ZBH is projected to trade between $153.86 and $303.09, averaging $207.95 — a potential gain of +152% from today's $82.56. That is up +5% on the projected 2034 average. Momentum favours further upside here.
Zimmer Biomet Holdings, Inc.'s 2040 outlook centres on $310.06, within a $219.98 to $473.44 range. That is up +49% on the projected 2035 average. That marks a +276% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, ZBH could reach as high as $891.65, with a base case around $544.93 and support toward $360.54 — roughly +560% from $82.56. Momentum favours further upside here.
Investing $1,000 in ZBH today (≈ 12.112403 ZBH) could be worth
$6,600.41
+$5,600.41 (+560%) by 2050 · US Dollar
Based on the average projected ZBH price of $544.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ZBHwould be worth at today's price.
$1,000 invested in ZBH on May 27, 2025 (≈ 10.614585 ZBH) would be worth
$876.34
-$123.66 (-12.4%) today · 0.88× · US Dollar
Based on a ZBH entry price of $94.21 vs. today's $82.56.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $85.38 | $966.97 | -3.3% |
| 1 month ago | $92.59 | $891.67 | -10.8% |
| 3 months ago | $100.99 | $817.51 | -18.2% |
| 6 months ago | $97.52 | $846.6 | -15.3% |
| 1 year ago | $94.21 | $876.34 | -12.4% |
| All time (5.0y) ago | $161.38 | $511.59 | -48.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ZBH forecast.
Our base-case forecast reaches $170.00 around 2033.
Implied market cap at $170.00: $32.89B
The multi-year forecast shows a rising price trajectory. In 2026, the min is $79.58, the avg is $85.50, the max is $115.89, with ROI 0, and sentiment NEUTRAL. In 2027 the avg rises to $109.61 and the max to $140.51, with ROI 28.2% and a BULLISH sentiment.
In 2028 the avg is $115.65, max $152.11, ROI 35.3%, BULLISH. 2029 shows avg $123.16, max $165.34, ROI 44%, BULLISH. 2030 projects avg $140.19, min $109.32, max $191.53, ROI 64%, BULLISH.
2031 shows avg $143.95, max $199.72, ROI 68.4%. 2032: avg $167.44, max $235.58, ROI 95.8%. 2033: avg $204.54, min $154.24, max $291.45, ROI 139.2%. 2034: avg $213.95, min $159.76, max $308.48, ROI 150.2%.
2035: avg $226.48, min $167.54, max $330.14, ROI 164.9%. 2040: avg $341.64, min $242.36, max $521.72, ROI 299.6%. 2050: avg $608.95, min $402.86, max $996.50, ROI 612.2%. The sentiment remains BULLISH across these years.
These are estimates, not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $140.19, with a min of $109.32 and a max of $191.53, and an ROI of 64%; sentiment BULLISH.
Forecasts show a bullish path in 2027-2050, with the 2027 avg $109.61 and 2050 avg $608.95; ROI rises from 28.2% in 2027 to 612.2% in 2050.
Yes. In 2033 the min is $154.24, the avg is $204.54, and the max is $291.45, with a bullish sentiment and ROI 139.2%.
For 2026 the min is $79.58, the avg is $85.50, the max is $115.89, ROI 0%, and sentiment NEUTRAL.
The 2050 forecast shows an avg price of $608.95, with a min of $402.86 and a max of $996.50, ROI 612.2%, sentiment BULLISH.
Zimmer Biomet Holdings, Inc. Community Discussion
0Share your Zimmer Biomet Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.